Dutton adds new medicines to Pharmaceutical Benefits Scheme

SUFFERERS of cystic fibrosis and a rare disease that attacks organ function will be able to access cheaper treatments from December.

Health Minister Peter Dutton today announced two new medicines for the diseases would be listed on the Pharmaceutical Benefits Scheme.

The medicines, Kalydeco, for cystic fibrosis and Soliris, or atypical haemolytic uraemic syndrome, will be listed from December 1.

Mr Dutton said listing the Kalydeco medicine would help more than 250 Australians affected by cystic fibrosis, saving about $300,000 a year for each patient.

He also said listing the Soliris medicine, for the ultra-rare aHUS condition, would help sufferers and their families meet the $500,000 annual cost of that medicine.

Listing both medicines on the PBS will cost the government about $238 million over the next four years, the drug manufacturers will have to meet some conditions prior to the listing.
- APN NEWSDESK
 



One arrested as pre-poll marred by stolen, soiled signs

Premium Content One arrested as pre-poll marred by stolen, soiled signs

Police warn they will take action against election damage.

Labor commits to ‘second Bruce Highway’

Premium Content Labor commits to ‘second Bruce Highway’

Queensland Election 2020 : Labor commits to ‘second Bruce Highway’

Gympie Magistrates Court appearances for today

Premium Content Gympie Magistrates Court appearances for today

Here is a list of matters listed at Gympie Magistrates Court